Radiolabelled Services - Chemistry & Metabolism Strategies

Organizing a radiolabelled drug development program requires significant planning and in-depth scientific expertise in radiosynthetic chemistry, metabolism, and pharmacokinetics (PK).

Pharmaron has a strong track record of supporting our clients’ radiolabelled metabolism programs from preclinical to clinical development. Our integrated services for small molecules and biologics offer comprehensive radioisotopic and DMPK expertise, enabling us to fully characterize your compound’s ADME properties. These programs have crucial endpoints to meet, and our team has the scientific understanding to guide you through the process.

Discover more about Pharmaron’s fully integrated radiolabelled drug development services for the entire development program, from radiosynthesis to non-clinical and clinical development.